Publication:
Utilization of cross-matched blood for elective hysterectomy in a tertiary care center: A retrospective review

dc.contributor.authorSomkiat Aroonpruksakulen_US
dc.contributor.authorNattaya Raykateerarojen_US
dc.contributor.authorKitikhun Phumkokraken_US
dc.contributor.authorParichart Permpikulen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2019-08-23T11:44:50Z
dc.date.available2019-08-23T11:44:50Z
dc.date.issued2018-09-01en_US
dc.description.abstract© 2018, Medical Association of Thailand. All rights reserved. Objective: To determine the incidence of perioperative blood transfusion in cross-matched patients undergoing elective hysterectomy at Siriraj Hospital, and to identify the associated risk factors. Materials and Methods: This is a retrospective chart review of patients undergoing elective hysterectomy from 2013 to 2014. The details of each patient were recorded: demography, American Society of Anesthesiologists [ASA] physical status class, diagnosis, preoperative hematocrit, route of hysterectomy, and uterine or mass size. Independent sample’s t-test was used to analyze continuous variables, and the risk factors for blood transfusion were analyzed by using univariate analysis and multiple logistic regression. Results: A total of 3,219 patients had elective hysterectomy during study period; 644 cross-matched patients were enrolled in this study and 144 patients were blood transfused in their perioperative period; of which, the incidence was 22.4% (95% CI 19.3 to 25.7). From univariate analysis, the significant risk factors for perioperative blood using were the diagnosis (beyond myoma uteri and gynecologic carcinoma), size of mass (bigger than 5 centimeters), preoperative hematocrit (less than 35%), ASA class III-IV and vaginal hysterectomy. However, when calculated by using multivariate analysis, the vaginal hysterectomy was not a significant factor, contrary to the gynecologic carcinoma, which had a significant risk. Conclusion: In elective hysterectomy cases, the medical team should order cross-matching blood when the patient has the risks: pre-operative anemia, larger than 5 centimeters mass, ASA class III-IV and diagnosis beyond myoma uteri.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.101, No.9 (2018), S143-S147en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-85064214501en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46346
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064214501&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUtilization of cross-matched blood for elective hysterectomy in a tertiary care center: A retrospective reviewen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064214501&origin=inwarden_US

Files

Collections